1 / 3

Temporary Cardiac Pacing Wires Leads Market to Witness an Outstanding Growth by 2026

The global temporary cardiac pacing wires & leads market is anticipated to account for over US$ 411.5 Mn in terms of value by 2026 end.<br><br>For Detailed Insights On Enhancing Your Product Footprint, Request For A Sample Here @ https://www.persistencemarketresearch.com/samples/25129

Manoj7645
Download Presentation

Temporary Cardiac Pacing Wires Leads Market to Witness an Outstanding Growth by 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Temporary Cardiac Pacing Wires Leads Market Poised to Expand at a Robust Pace Over 2018-2026 The prevalence of arrhythmia and cardiovascular diseases is rising and expected to con?nue growing throughout the forecast period. According to the latest research by the company, the global temporary cardiac pacing wires & leads market is an?cipated to account for over US$ 411.5 Mn in terms of value by 2026 end. The report on the temporary cardiac pacing wires & leads market indicates that the market is projected to have significant growth poten?al through 2022. The minimally-invasive procedure for transvenous pacing, by techniques type, is projected to account for the largest revenue share throughout the forecast period. The increasing adop?on of the minimally-invasive technique for temporary pacing during emergencies such as acute myocardial infarc?on and heart block is expected to drive the market for temporary cardiac pacing wires & leads in the near future. The favorable reimbursement scenario for the treatment of cardiovascular diseases, as the burden for cardiovascular diseases con?nues to increase in developing and under-developed economies, contributes to the growth of the temporary cardiac pacing wires & leads market. Significant growth in the number of cardiac surgeries is also spurring the market of temporary cardiac pacing wires & leads. According to the Centers for Disease Control and Preven?on (CDC), in the United States, every year,

  2. about 735,000 Americans experience heart a?acks. An es?mated 2.7–6.1 Million people in the United States have atrial fibrilla?on, which is expected to further increase with the aging of the U.S. popula?on, and more than 750,000 hospitaliza?ons occur each year due to atrial fibrilla?on. For Detailed Insights On Enhancing Your Product Footprint, Request For A Sample Here  @ https://www.persistencemarketresearch.com/samples/25129 The increasing number of cardiac surgeries, primarily among the geriatric popula?on, along with the an?cipated increase in the number of people undergoing cardiothoracic surgeries are expected to drive the temporary cardiac pacing wires & leads market during the forecast period. The rapidly aging popula?on also contributes to significant growth in the demand for temporary cardiac pacing wires & leads, leading to the growth of the temporary cardiac pacing wires & leads market. According to the Popula?on Reference Bureau, (2016), the number of Americans aged 65 and above is projected to grow to more than double – from 46 Million to over 98 Million – by 2060 and the 65-and-older age group’s share of the total popula?on will rise to nearly to 24% from 15%. Technological advancements in cardiac devices are also driving the growth of the temporary cardiac pacing wires & leads market. The increasing demand for pacemakers, owing to the growing prevalence of heart diseases, primarily due to rising obesity, unhealthy lifestyles, smoking, drug abuse and excessive consump?on of alcohol among the young popula?on, is leading to various heart disorders such as bradycardia and heart block. This is expected to further surge the demand for temporary cardiac pacing wire and leads during the forecast period. Manufacturing companies in the temporary cardiac pacing wires & leads market are focusing on the development of high-end technology devices and further aiming towards launching devices used in minimally-invasive techniques. The launch of new products integrated with advanced technologies that ease treatment procedures and provide improved results to pa?ents also contributes to the growth of the temporary cardiac pacing wire and leads market. For instance, in October 2016, BioTrace Medical, Inc. received the U.S. Food and Drug Administra?on 510(k) clearance to market a new Tempo Lead, an innova?ve temporary pacing lead designed for use in procedures in which temporary pacing is indicated, including transcatheter aor?c valve replacement (TAVR) and electrophysiology (EP) procedures. To Get Extensive Insights On Key Trends, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/25129 The increasing demand for cardiovascular surgeries is expected to contribute to the sales of leads and wires and in turn, contribute to the growth of the temporary cardiac pacing wires & leads market. The global temporary cardiac pacing wires & leads market has been segmented on the basis of product type, applica?on, technique, age group and end user. In terms of revenue, the cardiac pacing leads/catheter segment by product type in the temporary cardiac pacing wires & leads market is expected to hold a significant share over the forecast period. The report tracks some of the key companies opera?ng in the temporary cardiac pacing wires & leads

  3. market such as Medtronic Plc., Becton, Dickinson and Company (C.R. Bard), B. Braun Melsungen AG, Abbo? Laboratories (St. Jude Medical), Edwards Lifesciences Corpora?on, Teleflex Incorporated, Oscor Inc., Vance Street Capital LLC (A&E Medical Corpora?on), Osypka AG and BioTrace Medical Inc., among others. About us: Persistence Market Research (PMR) is a third-pla?orm research firm. Our research model is a unique collabora?on of data analy?cs and market research methodology to help businesses achieve op?mal performance. To support companies in overcoming complex business challenges, we follow a mul?-disciplinary approach. At PMR, we unite various data streams from mul?-dimensional sources. By deploying real-?me data collec?on, big data, and customer experience analy?cs, we deliver business intelligence for organiza?ons of all sizes. Contact us: Persistence Market Research 305 Broadway 7th Floor, New York City, NY 10007, United States, USA – Canada Toll Free: +1800-961-0353 Email: sales@persistencemarketresearch.com Web: www.persistencemarketresearch.com

More Related